Balance Transfer for Home Loans & Personal Loans, like
most other financial products has fairly stringent documentation requirements.
Not exact matches
These risks and uncertainties include, among
others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and
other patent litigation, related to any of our
products or
products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our
products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their
products; there may be a reduction in payment rate or reimbursement for the company's
products or an increase in the company's
financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's
products; the company's
products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's
most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.
«It is still important for people to think of any
other alternative they can to avoid having to turn to a
financial product that is the
most expensive, and often the
most difficult to repay,» he said.
Important factors that could cause our actual results and
financial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on For
financial condition to differ materially from those indicated in the forward - looking statements include, among
others, the following: our ability to successfully and profitably market our
products and services; the acceptance of our
products and services by patients and healthcare providers; our ability to meet demand for our
products and services; the willingness of health insurance companies and
other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from
other cancer screening and diagnostic
products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our
products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our
products and services; our ability to successfully develop new
products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the
other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of
Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on For
Financial Condition and Results of Operations sections of our
most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 10 - Q.
While the Committee believes that
financial performance should be the
most significant driver of compensation,
other factors that drive long - term value for stockholders are also taken into account by the Committee, including improvements in market share, successful
product launches, achievement of strategic objectives and customer satisfaction.
«The surge in non-iPad shipments in the fourth quarter was achieved at considerable
financial cost, with sharp price reductions across
most of the competing Android tablets and actual
product giveaways from a number of vendors as part of promotional efforts for
other electronic
products,» Alexander noted.
Given our strong capital level, very low charge - offs and delinquency from loans as well as outstanding performance from investments, Star One continues to outperform
most other financial institutions and provide exceptional
products and services for our members.
Savings accounts will earn interest, but
most savings accounts typically offer lower interest rates than
other financial products like certificates of deposit (CDs).
Online lenders provide not only the
most convenient unsecured loans in the
financial sector, they also offer the lowest rates, due to low company overhead and stiff online competition with
other financial institutions that market their
products on the Internet, both of which can add up to significant savings for you over the term of your new loan.
Most loans and
financial products come along with a life insurance premium but car loans can include
other insurances to make sure that the loan is repaid if an unexpected event damages the vehicle beyond recovery or the owner is unable to repay the loan for a justifiable reason.
Most of the
other arguments focus on the author's affiliations — AIG
Financial Products and Vanguard.
If you agree with the advice being given, then buy the recommended securities and
other financial products through the
most inexpensive channels possible.
No,
most Baby Boomers are going to slowly sell their equities, and move into
other financial products, which will still drive the economy.
Fixed annuities also pay life insurance agents the
most money in commissions per buck invested, compared to every
other type of non-life insurance
financial product a
financial salesperson can sell today - except variable annuities.
My clients are
most commonly investment managers, investment
product providers,
financial intermediaries or
other financial institutions such as banks or insurance companies.
Most financial planners and experts agree on one thing in relation to whole life plans: They can be a good investment when combined with
other financial products.
Most large life insurance companies sell
other financial products and services which might be helpful to you.
But there are many
other factors that go into the auto insurer decision - making process, including perceived level of customer service, the company's
other insurance and
financial products, as well as — let's be honest — which auto insurance company has the
most entertaining commercials.
Unlike
most other life insurance companies they don't offer complicated
products that only an experienced
financial planner can understand.
Variable annuities can offer a package of benefits that are for the
most part unmatched by any
other type of
financial product on the market today.
Certainly,
financial gurus like Dave Ramsey and Suze Orman are against life insurance for any reason
other than a death benefit, but remember, while speaking out against
most life insurance
products, they are -LSB-...]
Most investors should consider annuity
products only after they have made maximum contributions to their 401 (k) s and
other pre-tax retirement plans, according to the
Financial Industry Regulatory Authority.
Having a mortgage life insurance policy can also be coupled with
other term and permanent life insurance
products to give you the
most financial protection for your family's future.
Though Ripple says that xRapid, a blockchain
product that uses XRP for on - demand liquidity, is more cost - effective and efficient than its
other blockchain solutions,
most financial institutions have opted to instead connect to RippleNet.
Cryptocurrencies are not officially recognized as
financial products in South Korea — like in
most other countries — and no regulations exist around them.
About Blog We write about things related to personal finance, investment,
financial planning, insurance, real estate, stock market and
other financial products that interest us
most, and which we feel will help
others make better
financial decisions about their money.
SUMMARY Experienced Bilingual & Bicultural Senior
Financial & Payments Executive in Financial Services, Accounting, Finance, Payments Products & Business Development with +25 years serving in positions of increasing responsibilities in the Payment Processing through Gateways Systems, ATM & Mobile Banking, Wallets, E-Commerce, Credit / Debit Cards, e-Lending, Leasing, banking and other financial services most recently in
Financial & Payments Executive in
Financial Services, Accounting, Finance, Payments Products & Business Development with +25 years serving in positions of increasing responsibilities in the Payment Processing through Gateways Systems, ATM & Mobile Banking, Wallets, E-Commerce, Credit / Debit Cards, e-Lending, Leasing, banking and other financial services most recently in
Financial Services, Accounting, Finance, Payments
Products & Business Development with +25 years serving in positions of increasing responsibilities in the Payment Processing through Gateways Systems, ATM & Mobile Banking, Wallets, E-Commerce, Credit / Debit Cards, e-Lending, Leasing, banking and
other financial services most recently in
financial services
most recently in the p...